ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/09/20 | 2,557.5 | 2,631.5 | 2,516.5 | 2,536 | +113 | +4.7% | 1,576,400 |
2024/09/19 | 2,450.5 | 2,496 | 2,423 | 2,423 | +5 | +0.2% | 489,600 |
2024/09/18 | 2,407 | 2,455 | 2,378 | 2,418 | +18 | +0.8% | 424,500 |
2024/09/17 | 2,452.5 | 2,462.5 | 2,350 | 2,400 | -67.5 | -2.7% | 644,000 |
2024/09/13 | 2,491 | 2,510 | 2,433 | 2,467.5 | -50 | -2% | 530,900 |
2024/09/12 | 2,525 | 2,558 | 2,492 | 2,517.5 | +35.5 | +1.4% | 438,500 |
2024/09/11 | 2,537.5 | 2,606 | 2,451 | 2,482 | -68 | -2.7% | 667,300 |
2024/09/10 | 2,510 | 2,579.5 | 2,477.5 | 2,550 | +40.5 | +1.6% | 457,000 |
2024/09/09 | 2,421 | 2,515.5 | 2,410.5 | 2,509.5 | -14.5 | -0.6% | 716,700 |
2024/09/06 | 2,517 | 2,550 | 2,471 | 2,524 | -26 | -1% | 870,500 |
2024/09/05 | 2,563 | 2,608 | 2,512 | 2,550 | -63 | -2.4% | 873,600 |
2024/09/04 | 2,581 | 2,625 | 2,547 | 2,613 | -70 | -2.6% | 1,069,300 |
2024/09/03 | 2,599 | 2,705 | 2,599 | 2,683 | +73 | +2.8% | 962,300 |
2024/09/02 | 2,572 | 2,629 | 2,562.5 | 2,610 | +50 | +2% | 767,500 |
2024/08/30 | 2,559 | 2,598.5 | 2,510 | 2,560 | +29.5 | +1.2% | 958,500 |
2024/08/29 | 2,599 | 2,618 | 2,508 | 2,530.5 | -94.5 | -3.6% | 1,031,300 |
2024/08/28 | 2,527.5 | 2,652.5 | 2,523.5 | 2,625 | +97.5 | +3.9% | 1,871,300 |
2024/08/27 | 2,408 | 2,527.5 | 2,394 | 2,527.5 | +202 | +8.7% | 1,704,900 |
2024/08/26 | 2,182 | 2,327 | 2,141.5 | 2,325.5 | +144 | +6.6% | 839,700 |
2024/08/23 | 2,200 | 2,211 | 2,160 | 2,181.5 | -33.5 | -1.5% | 592,900 |
2024/08/22 | 2,220 | 2,275 | 2,205.5 | 2,215 | -19.5 | -0.9% | 669,300 |
2024/08/21 | 2,357.5 | 2,360.5 | 2,218 | 2,234.5 | -92 | -4% | 1,038,800 |
2024/08/20 | 2,381 | 2,395 | 2,259.5 | 2,326.5 | -31 | -1.3% | 996,500 |
2024/08/19 | 2,310 | 2,424 | 2,289.5 | 2,357.5 | +120.5 | +5.4% | 1,363,800 |
2024/08/16 | 2,179.5 | 2,301 | 2,177 | 2,237 | +98 | +4.6% | 988,800 |
2024/08/15 | 2,160 | 2,162 | 2,102.5 | 2,139 | -37 | -1.7% | 1,106,500 |
2024/08/14 | 2,242 | 2,271.5 | 2,081.5 | 2,176 | -73.5 | -3.3% | 1,747,400 |
2024/08/13 | 2,320 | 2,348.5 | 2,206.5 | 2,249.5 | -76 | -3.3% | 1,157,700 |
2024/08/09 | 2,453.5 | 2,531 | 2,220 | 2,325.5 | -128.5 | -5.2% | 1,735,600 |
2024/08/08 | 2,389 | 2,483 | 2,362 | 2,454 | +40.5 | +1.7% | 554,900 |
2024/08/07 | 2,434 | 2,519.5 | 2,375.5 | 2,413.5 | -37 | -1.5% | 967,900 |
2024/08/06 | 2,398.5 | 2,466 | 2,320 | 2,450.5 | +351 | +16.7% | 1,184,500 |
2024/08/05 | 2,274.5 | 2,384.5 | 2,054.5 | 2,099.5 | -392.5 | -15.8% | 1,973,000 |
2024/08/02 | 2,560 | 2,593 | 2,480 | 2,492 | -198 | -7.4% | 1,273,900 |
2024/08/01 | 2,730 | 2,738.5 | 2,625 | 2,690 | -83 | -3% | 914,900 |
2024/07/31 | 2,836 | 2,875.5 | 2,743.5 | 2,773 | -14 | -0.5% | 1,093,900 |
2024/07/30 | 2,710 | 2,796 | 2,707 | 2,787 | +51 | +1.9% | 620,100 |
2024/07/29 | 2,660 | 2,759 | 2,656 | 2,736 | +85.5 | +3.2% | 672,200 |
2024/07/26 | 2,629.5 | 2,701 | 2,623.5 | 2,650.5 | +12.5 | +0.5% | 582,300 |
2024/07/25 | 2,643 | 2,692.5 | 2,617 | 2,638 | -70 | -2.6% | 689,300 |
2024/07/24 | 2,718.5 | 2,753 | 2,660 | 2,708 | -42 | -1.5% | 681,100 |
2024/07/23 | 2,730 | 2,769 | 2,702 | 2,750 | +6.5 | +0.2% | 781,200 |
2024/07/22 | 2,811 | 2,864 | 2,666.5 | 2,743.5 | -85 | -3% | 1,261,200 |
2024/07/19 | 2,909 | 2,920 | 2,799 | 2,828.5 | -66.5 | -2.3% | 907,900 |
2024/07/18 | 2,815.5 | 2,929 | 2,815 | 2,895 | +36 | +1.3% | 1,226,700 |
2024/07/17 | 2,770 | 2,868 | 2,721.5 | 2,859 | +112 | +4.1% | 1,104,000 |
2024/07/16 | 2,810 | 2,819.5 | 2,719.5 | 2,747 | -53 | -1.9% | 797,800 |
2024/07/12 | 2,700.5 | 2,818 | 2,700 | 2,800 | +56 | +2% | 1,118,700 |
2024/07/11 | 2,770 | 2,809.5 | 2,661.5 | 2,744 | +0.5 | ±0% | 1,663,900 |
2024/07/10 | 2,600 | 2,743.5 | 2,600 | 2,743.5 | +156 | +6% | 1,595,900 |
51~
100
件表示中 / 2809件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 296,500円 | +56.7% | +357.2% | 0.00% | 27.46倍 | 6.54倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
ロート | 288,000円 | +18.2% | +4.2% | 1.15% | 20.41倍 | 2.60倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 178,700円 | 0.0% | +50.6% | 1.90% | 18.84倍 | 2.12倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 489,500円 | +22.6% | +68.1% | 2.78% | 13.04倍 | 1.26倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 423,800円 | +7.3% | -3.8% | 2.12% | 19.67倍 | 1.14倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム